The aim of this study is to assess the prevalence of non-opioid drug use among opioid-addicted, buprenorphine injecting individuals in Georgia, during and after a 12-week course of buprenorphine–naloxone (Suboxone®) or methadone. (Source: Journal of Substance Abuse Treatment)
Opioid Addicted Buprenorphine Injectors: Drug Use During and After 12-Weeks of Buprenorphine–Naloxone or Methadone in the Republic of Georgia
Call 1 (888) 460-6556 to speak with a counselor.
